Vitamins China E-News(Vitamins China E-News 202509)

Published Date：Sep 1, 2025

Monthly Report

Vitamins & Minerals

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.

China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.

Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:

Breaking news from China and abroad
The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations

Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.

202512

202511

202510

202509

202508

202507

202506

202505

202504

202503

Table of Contents

Editor's Note

Published Date: Dec 25, 2025

Free

The revised National Food Safety Standard for Good Manufacturing Practice of Health Foods will be released soon.

In Sept. 2025, Henan Taifeng Bio was officially launched its new drug, Menaquinone Soft Capsules.

In Sept. 2025, Aland's shareholders are considering selling their collectively held shares, with the equity valuation expected to exceed USD1.5 billion.

Project Progress of Multiple Companies

Haineng Bio's 25-Hydroxyvitamin D3 production base project has entered the core equipment installation and commissioning stage.
EI report for Hegno Pharma's vitamin project was approved.
EI report for Chifeng Pharma's vitamin B2, griseofulvin relocation and renovation project was publicized.

The USD/RMB exchange rate in this Report is USD1.00=CNY7.1072 on 1 Sept. 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.

Governmental Direction

Published Date: Dec 24, 2025

Market Analysis

Published Date: Dec 24, 2025

Company Dynamics

Published Date: Dec 24, 2025

Price Update

Published Date: Dec 24, 2025

Import and Export

Published Date: Dec 24, 2025

News in Brief

Published Date: Dec 24, 2025

Available

Pre-order

202512

202511

202510

202509

202508

202507

Price Details

[Total Product Price] $0

Periodical 202509

$0

Selected Products

1

Total Amount $0

Buy Now

Add to cart

About Us

CCM is a professional industry data platform. Combining real-time collection with expert analysis, we deliver comprehensive, timely, and reliable global market intelligence, product data, and business opportunities for enterprises and traders.

Explore CCM

Partner

Get in touch with us

Feedback